Biocept Operating Income

Biocept (BIOC) currently reports a operating income of $-37M as of June 2023. That compares with $-10M in the prior-year period — down 271.0% year over year. Use the charts on this page to explore Biocept's operating income history and peer comparisons.

Biocept's operating income decreased from $-10M to $-37M — a 271.0% year-over-year decrease (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Biocept reported $-37M in operating income as of June 2023. That compares with $-10M in the prior-year period — down 271.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-37M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Biocept, and consider following BIOC for alerts when major investors trade the stock.

Biocept is classified in the Healthcare sector. On operating income, it currently shows $-37M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BIOC with unrelated industries.